Tumor heterogeneity in metastatic prostate cancer: Limitations on the efficacy of prostate-specific membrane antigen radioligand therapy. // Asian Journal of Urology. – URL: https://www.sciencedirect.com/science/article/pii/S2214388225001195?dgcid=rss_sd_all
Tumor heterogeneity in metastatic prostate cancer: Limitations on the efficacy of prostate-specific membrane antigen radioligand therapy. Asian Journal of Urology. https://www.sciencedirect.com/science/article/pii/S2214388225001195?dgcid=rss_sd_all
“Tumor heterogeneity in metastatic prostate cancer: Limitations on the efficacy of prostate-specific membrane antigen radioligand therapy.” Asian Journal of Urology.
@article{article37091,
title = {Tumor heterogeneity in metastatic prostate cancer: Limitations on the efficacy of prostate-specific membrane antigen radioligand therapy},
journal = {Asian Journal of Urology},
url = {https://www.sciencedirect.com/science/article/pii/S2214388225001195?dgcid=rss_sd_all}
}
Objective To assess prostate‐specific antigen (PSA) testing according to income, age, and region of residence in Sweden. Patients and Methods We conducted a nationwide, population‐based open cohort study of men aged 40–90 years in...